V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270015061 | 270010897 | null | 98 | Palliative (P) | null | 2017-11-13 | OXALIPLATIN | N | N | 270023749 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270015062 | 270010898 | 1.85 | 76.5 | Neo-adjuvant (N) | 2015-05-02 | 2015-05-08 | Bevacizumab + Capecitabine | N | N | 270023765 | CETUXIMAB + CISPLATIN + FU |
| 270015063 | 270015077 | 1.84 | 83 | Curative (C) | 2017-10-09 | 2017-10-11 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 270023795 | DOCETAXEL |
| 270015064 | 270010904 | 1.72 | 75.9 | Palliative (P) | 2017-11-17 | 2017-12-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 270023796 | PACLITAXEL |
| 270015065 | 270010905 | null | 48 | Adjuvant (A) | 2016-03-27 | 2016-05-06 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 270023952 | TRIFLURIDINE TIPIRACIL |
| 270015066 | 270010907 | null | 89.9 | Curative (C) | 2013-10-21 | 2013-10-21 | Vinorelbine (oral) | N | N | 270024030 | IRINOTECAN + RALTITREXED |
| 270015067 | 270010908 | 1.77 | 61 | Curative (C) | 2017-08-28 | 2017-08-31 | Carbo F | N | N | 270024128 | GEMCARBO |
| 270015068 | 270010909 | 1.94 | 79 | Curative (C) | 2017-05-20 | 2017-06-03 | DA 3 + 10 | N | N | 270024199 | CARBOPLATIN + RT |
| 270015069 | 270010910 | 1.76 | null | Palliative (P) | 2016-07-19 | 2016-07-26 | RATHL TRIAL | N | N | 270024404 | GEMCITABINE + VINORELBINE |
| 270015070 | 270010913 | null | 64.5 | Neo-adjuvant (N) | 2018-02-15 | 2018-02-22 | Bortezomib | N | N | 270024602 | CAPECITABINE + OXALIPLATIN + MDG |
| 270015071 | 270015082 | null | null | null | 2016-03-01 | 2017-12-25 | Hydroxycarbamide | N | N | 270024602 | DTPACE |
| 270015072 | 270010914 | 1.62 | null | Curative (C) | 2011-04-27 | 2013-05-13 | IBRUTINIB | N | null | 270024629 | CARBOPLATIN + PACLITAXEL |
| 270015073 | 270010915 | 1.64 | 50.6 | Palliative (P) | 2015-01-09 | 2015-02-03 | CAM-PLEX Trial | 2 | N | 270024718 | CUFOX TRIAL |
| 270015074 | 270010916 | 1.65 | null | Palliative (P) | 2015-10-18 | 2015-11-14 | FOXTROT TRIAL | N | N | 270024838 | CAPECITABINE + CARBOPLATIN |
| 270015075 | 270015084 | null | null | Disease modification (D) | 2017-11-04 | 2017-11-19 | PEMBROLIZUMAB | N | N | 270024838 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270015076 | 270015085 | null | null | Curative (C) | 2017-08-08 | 2017-08-09 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 270025265 | ABIRATERONE |
| 270015077 | 270015085 | 1.66 | 70 | Palliative (P) | 2015-06-13 | 2015-06-14 | Docetaxel 75mg/m2 (21 day) | Y | N | 270025265 | DOCETAXEL |
| 270015078 | 270019324 | null | 54.25 | Curative (C) | 2017-01-21 | 2017-02-24 | Cetuximab + CISPLATIN + FLUOROURACIL | N | null | 270025280 | IRINOTECAN + RALTITREXED |
| 270015079 | 270010923 | null | 76.4 | Neo-adjuvant (N) | 2015-11-22 | 2015-11-24 | Docetaxel 75mg/m2 (21 day) | N | N | 270025303 | CETUXIMAB + CISPLATIN + FU |
| 270015080 | 270010923 | 1.83 | 100 | null | 2017-03-25 | 2017-03-25 | Cisplatin + Docetaxel +Fluorouracil | N | N | 270025303 | CARBOPLATIN + RT |
| 270015081 | 270010924 | 1.63 | 80.1 | Palliative (P) | 2019-01-10 | 2019-03-15 | SCOT TRIAL | N | N | 270003466 | CARBOPLATIN + RT |
| 270015082 | 270010925 | 1.9 | 82.4 | Palliative (P) | 2018-06-25 | 2018-06-25 | Bevacizumab + Irinotecan + MdG | N | N | 270005582 | IRINOTECAN + RALTITREXED |
| 270015083 | 270010925 | 1.71 | 57.2 | Curative (C) | 2014-08-14 | 2014-08-21 | ECHELON 1 TRIAL | 02 | N | 270005582 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 270015084 | 270019325 | 1.78 | 70.4 | Adjuvant (A) | 2016-02-20 | 2016-02-20 | CARBOPLATIN + GEMCITABINE | 02 | N | 270017515 | RATHL TRIAL |
| 270015085 | 270015088 | null | null | Palliative (P) | 2016-11-21 | 2016-11-26 | CARBO + FLUOROURACIL | N | N | 270017515 | CARBOPLATIN + CETUXIMAB + FU |
| 270015086 | 270015089 | 1.73 | null | Disease modification (D) | 2018-05-25 | 2018-05-27 | AFLIBERCEPT | N | N | 270017956 | CAPECITABINE + CETUXIMAB + IRINOTECAN |
| 270015087 | 270010930 | 1.68 | 69 | Palliative (P) | 2017-04-27 | 2017-04-29 | AFLIBERCEPT | 02 | N | 270019196 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 270015088 | 270015091 | null | null | Palliative (P) | null | 2019-03-11 | CAPECITABINE + CETUXIMAB + IRINOTECAN | null | null | 270019361 | CAP + RT |
| 270015089 | 270010934 | 1.61 | 92.6 | Palliative (P) | 2019-05-23 | 2019-05-28 | Paclitaxel 7 day | null | N | 270019361 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270015090 | 270010934 | 1.82 | 43.4 | Curative (C) | 2018-12-01 | 2018-12-03 | Cisplatin + Etoposide po&iv 3 day | N | N | 270019361 | CISPLATIN + VINORELBINE |
| 270015091 | 270010934 | 1.67 | null | Curative (C) | 2018-04-25 | 2018-05-04 | Carbo F | N | null | 270019361 | CARBOPLATIN + RT |
| 270015092 | 270010935 | 1.57 | 70 | null | 2014-09-13 | 2014-09-14 | Raltitrexed | null | N | 270022964 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270015093 | 270017331 | 1.74 | 109 | Adjuvant (A) | 2016-12-28 | 2017-12-23 | FLUOROURACIL + MITOMYCIN + RT | N | N | 270022964 | CETUXIMAB + OXALIPLATIN |
| 270015094 | 270010938 | 1.67 | 106 | Disease modification (D) | 2016-09-27 | 2016-10-06 | CARBOPLATIN + RT | 02 | N | 270004568 | IBRUTINIB |
| 270015095 | 270015095 | null | null | Disease modification (D) | 2017-09-22 | 2017-09-29 | GEMCITABINE + CARBO + RITUXIMAB | N | N | 270021937 | R-GEM-P |
| 270015096 | 270006446 | 1.61 | 65 | Curative (C) | 2013-07-24 | 2013-07-31 | ABVD | N | N | 270021937 | ABVD |
| 270015097 | 270017921 | null | 66.3 | null | 2013-10-27 | 2013-12-10 | ABVD | null | null | 270000027 | ABVD |
| 270015098 | 270006452 | null | null | Curative (C) | null | 2016-10-17 | ABVD | null | null | 270000059 | ABVD |
| 270015099 | 270006454 | 1.8 | 76.6 | Adjuvant (A) | 2013-10-12 | 2014-03-25 | ABVD | 2 | N | 270000082 | ABVD |
| 270015100 | 270006460 | 1.67 | 66 | Curative (C) | 2015-11-26 | 2016-02-18 | ABVD | N | N | 270000131 | ABVD |
| 270015101 | 270006466 | 1.65 | 58.4 | null | 2017-10-19 | 2017-10-19 | ABVD | N | N | 270000161 | ABVD |
| 270015102 | 270006469 | null | null | null | 2016-05-15 | 2016-05-29 | ABVD | null | null | 270000187 | ABVD |
| 270015103 | 270006472 | null | null | Curative (C) | 2013-06-05 | 2013-06-05 | ABVD | null | null | 270000204 | ABVD |
| 270015104 | 270006476 | 1.65 | 78.1 | Curative (C) | 2017-09-04 | 2017-12-27 | ABVD | 02 | N | 270000221 | ABVD |
| 270015105 | 270006481 | 1.68 | 77.3 | Curative (C) | 2017-01-28 | 2017-01-28 | ABVD | N | N | 270000246 | ABVD |
| 270015106 | 270006482 | 2 | 91 | Curative (C) | 2016-12-26 | 2017-01-22 | ABVD | 2 | N | 270000277 | ABVD |
| 270015107 | 270006484 | 1.74 | 88.6 | Curative (C) | 2015-02-25 | 2015-02-25 | ABVD | N | N | 270000295 | ABVD |
| 270015108 | 270006487 | 1.73 | 75.5 | null | 2016-06-10 | 2016-07-14 | ABVD | null | N | 270000310 | ABVD |
| 270015109 | 270006489 | 1.78 | 80.2 | Curative (C) | 2013-05-19 | 2013-05-24 | ABVD | N | N | 270000314 | ABVD |
| 270015110 | 270013093 | 1.74 | 59.4 | Curative (C) | 2016-11-22 | 2016-12-14 | ABVD | 02 | N | 270000332 | ABVD |